- 专利标题： Heteroaryl butanoic acid derivatives
-
申请号： US15104729申请日： 2014-12-18
-
公开(公告)号： US09981926B2公开(公告)日： 2018-05-29
- 发明人: Birgit Bollbuck , Christian Markert , Wolfgang Miltz , Till Roehn
- 申请人： Birgit Bollbuck , Christian Markert , Wolfgang Miltz , Till Roehn
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理机构： Genomics Institute of the Novartis Research Foundation
- 代理商 Daniel E. Raymond
- 优先权： EP13199138 20131220; EP14181155 20140815
- 国际申请： PCT/IB2014/067086 WO 20141218
- 国际公布： WO2015/092740 WO 20150625
- 主分类号： C07D257/04
- IPC分类号： C07D257/04 ; C07D401/00 ; C07D403/00 ; A61K31/41 ; C07D231/12 ; C07D401/12 ; C07D413/12 ; C07D417/12 ; C07D271/10 ; A61K45/06 ; A61K31/415 ; A61K31/422 ; A61K31/4245 ; A61K31/428 ; A61K31/4439
摘要：
The present invention describes novel heteroaryl butanoic acid derivatives that are good drug candidates especially with regard to leukotriene A4 hydrolase (LTA4H). The present invention also relates to pharmaceutical compositions comprising said novel heteroaryl butanoic acid derivatives, methods of using said compounds in the treatment of various diseases and disorders, and processes for preparing the said novel compounds.
公开/授权文献
- US20170015637A1 NOVEL HETEROARYL BUTANOIC ACID DERIVATIVES 公开/授权日：2017-01-19
信息查询
